These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 8052271)
21. Vincristine-laden platelet transfusion for patients with refractory thrombocytopenia. Ganti AK; Landmark JD; Kessinger A; Smith LM; Tarantolo SR In Vivo; 2006; 20(4):559-63. PubMed ID: 16900790 [TBL] [Abstract][Full Text] [Related]
22. A randomized controlled trial comparing plasma removal with white cell reduction to prevent reactions to platelets. Heddle NM; Klama L; Meyer R; Walker I; Boshkov L; Roberts R; Chambers S; Podlosky L; O'Hoski P; Levine M Transfusion; 1999 Mar; 39(3):231-8. PubMed ID: 10204584 [TBL] [Abstract][Full Text] [Related]
23. Generation of inflammatory cytokines and chemokines from peripheral blood mononuclear cells by HLA Class II antibody-containing plasma unit that was associated with severe nonhemolytic transfusion reactions. Sakagawa H; Miyazaki T; Fujihara M; Sato S; Yamaguchi M; Fukai K; Morioka M; Kato T; Azuma H; Ikeda H Transfusion; 2007 Jan; 47(1):154-61. PubMed ID: 17207244 [TBL] [Abstract][Full Text] [Related]
24. The use of PEG-rhuMGDF in platelet apheresis. Kuter DJ Stem Cells; 1998; 16 Suppl 2():231-42. PubMed ID: 11012195 [TBL] [Abstract][Full Text] [Related]
26. Febrile and allergic transfusion reactions after the transfusion of white cell-poor platelet preparations. Klüter H; Bubel S; Kirchner H; Wilhelm D Transfusion; 1999; 39(11-12):1179-84. PubMed ID: 10604243 [TBL] [Abstract][Full Text] [Related]
27. Are cytokines in platelet concentrates responsible for febrile transfusion reactions? Wadhwa M; Seghatchian J; Thorpe R Transfus Sci; 1997 Sep; 18(3):367-71. PubMed ID: 10175148 [TBL] [Abstract][Full Text] [Related]
28. Platelet transfusions in children: results of a randomized, prospective, crossover trial of plasma removal and a prospective audit of WBC reduction. Couban S; Carruthers J; Andreou P; Klama LN; Barr R; Kelton JG; Heddle NM Transfusion; 2002 Jun; 42(6):753-8. PubMed ID: 12147029 [TBL] [Abstract][Full Text] [Related]
29. Passenger leukocytes, cytokines, and transfusion reactions. Brand A N Engl J Med; 1994 Sep; 331(10):670-1. PubMed ID: 8052278 [No Abstract] [Full Text] [Related]
30. The relationship between the duration of platelet storage and the development of transfusion reactions. Sarkodee-Adoo CB; Kendall JM; Sridhara R; Lee EJ; Schiffer CA Transfusion; 1998 Mar; 38(3):229-35. PubMed ID: 9563401 [TBL] [Abstract][Full Text] [Related]
31. Platelet washing to prevent recurrent febrile reactions to leucocyte-reduced transfusions. Vo TD; Cowles J; Heal JM; Blumberg N Transfus Med; 2001 Feb; 11(1):45-7. PubMed ID: 11328571 [TBL] [Abstract][Full Text] [Related]
32. Immediate adverse reactions to platelet transfusions: whole blood derived versus apheresis platelets. Salam A; Hosain GM; Narvios A; Sazama K; Lichtiger B Mymensingh Med J; 2013 Jan; 22(1):143-7. PubMed ID: 23416822 [TBL] [Abstract][Full Text] [Related]
33. Survey of current practice for monitoring and management of platelet refractoriness in Italy. Quaglietta A; Nicolucci A; Accorsi P; Pompa A; Pierelli L; Iacone A Transfus Apher Sci; 2012 Dec; 47(3):271-6. PubMed ID: 22647683 [TBL] [Abstract][Full Text] [Related]
34. Septic reactions to platelet transfusions. A persistent problem. Morrow JF; Braine HG; Kickler TS; Ness PM; Dick JD; Fuller AK JAMA; 1991 Jul 24-31; 266(4):555-8. PubMed ID: 2061984 [TBL] [Abstract][Full Text] [Related]
35. Effect of storage of platelet concentrates in PAS-B, PAS-C, or plasma on transfusion reactions. van Hout FMA; Middelburg RA; van der Meer PF; Pors A; Wiersum-Osselton JC; Schipperus MR; Kerkhoffs JL; van der Bom JG Transfusion; 2019 Oct; 59(10):3140-3145. PubMed ID: 31503334 [TBL] [Abstract][Full Text] [Related]
36. Repeated exposure rather than the total volume of transfused components may influence the incidence of allergic transfusion reactions. Kato H; Nakayama T; Uruma M; Okuyama Y; Handa M; Tomiyama Y; Shimodaira S; Takamoto S Transfusion; 2015 Nov; 55(11):2576-81. PubMed ID: 26095126 [TBL] [Abstract][Full Text] [Related]
37. Combined plasma exchange and platelet transfusion in immune-mediated thrombocytopenic emergencies. Finn L; Tun H Transfus Apher Sci; 2013 Dec; 49(3):661-4. PubMed ID: 23856529 [TBL] [Abstract][Full Text] [Related]
38. Effect of storage time of platelet products on clinical outcomes after transfusion: a systematic review and meta-analyses. Kreuger AL; Caram-Deelder C; Jacobse J; Kerkhoffs JL; van der Bom JG; Middelburg RA Vox Sang; 2017 May; 112(4):291-300. PubMed ID: 28271517 [TBL] [Abstract][Full Text] [Related]
39. I am the 9%: Making the case for whole-blood platelets. Seheult JN; Triulzi DJ; Yazer MH Transfus Med; 2016 Jun; 26(3):177-85. PubMed ID: 27170206 [TBL] [Abstract][Full Text] [Related]
40. A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusions. Heddle NM; Klama LN; Griffith L; Roberts R; Shukla G; Kelton JG Transfusion; 1993 Oct; 33(10):794-7. PubMed ID: 8236418 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]